Pico145

1628287-16-0

C23H20ClF3N4O5

DMSO : >= 125 mg/mL (238.15 mM)

Membrane Transporter/Ion Channel; Neuronal Signaling

Pico145 is a remarkable inhibitor of TRPC1/4/5 channels, inhibits (?)-englerin A-activated TRPC4/TRPC5 channels, with IC₅₀s of 0.349 and 1.3 nM in cells, and shows no effect on TRPC3, TRPC6, TRPV1, TRPV4, TRPA1, TRPM2, TRPM8. IC50 & Target: IC50: 0.349 nM (TRPC4, cell assay), 1.3 nM (TRPC5, cell assay), 0.03 nM (TRPC4-TRPC1, cell assay), 0.2 nM (TRPC5-TRPC1, cell assay)^[1] In Vitro: Pico145 (Compound 31, C31) is a remarkable small-molecule inhibitor of TRPC1/4/5 channels, inhibits (?)-englerin A-activated TRPC4/TRPC5 channels, with IC₅₀s of 0.349 and 1.3 nM in cells; Pico145 shows no effect on TRPC3, TRPC6, TRPV1, TRPV4, TRPA1, TRPM2, TRPM8. Pico145 also inhibits human TRPC4-TRPC1 and TRPC5-TRPC1 concatemers expressed in HEK 293 Tet⁺ cells (IC₅₀, 0.03 nM and 0.2 nM, respectively). The potency of Pico145 can be reduced by increased (?)-englerin A concentration. Furthermore, Pico145 potently inhibits RPC4-TRPC1 channels activated by sphingosine 1-phosphate (S1P), and suppresses S1P-evoked Ca²⁺ entry through TRPC4-TRPC1 channels with an IC₅₀ of 0.011 nM. Pico145 also sensitizes EA-sensitive cancer cell line (Hs578T cells) (IC₅₀, 0.11 nM). Pico145 (100 nM) lacks effect on store-operated Ca²⁺ entry and histamine-evoked Ca²⁺ entry into endothelial cells^[1].